Kronos Bio

Top biotech licensing deals of Q1 2023
BioSpace
Thu, 03/30/23 - 11:03 am
biotech
licensing
Moderna Therapeutics
CytomX
Voyager Therapeutics
Neurocrine Biosciences
Kronos Bio
Genentech
Karuna Therapeutics
Goldfinch Bio
Roche offers up to $554M in biobucks to in-need Kronos for small-molecule discovery pact
Fierce Biotech
Mon, 01/9/23 - 10:39 am
Kronos Bio
biobucks
AML
Roche
Genentech
small molecule drugs
drug discovery
4 Biotech IPOs this Week: Kronos, Shattuck, Spruce and Aziyo
BioSpace
Sat, 10/10/20 - 11:48 pm
IPOs
biotech
Kronos Bio
Shattuck
Spruce Biosciences
Aziyo
Kronos Bio sets terms for IPO, flirting with billion-dollar unicorn valuation
Endpoints
Mon, 10/5/20 - 11:50 am
IPOs
Kronos Bio
NASDAQ
Bischofberger's Kronos files for IPO to run pivotal cancer trial
Fierce Biotech
Mon, 09/21/20 - 10:31 am
Kronos Bio
IPO
NASDAQ
AML
Kronos Bio raises $155M in private financing to advance lead leukemia drug into registration study next year
MedCity News
Tue, 08/25/20 - 10:28 am
Kronos Bio
leukemia
Gilead Sciences
entospletinib
Kronos Bio Appoints Former Gilead R&D Veteran as President and CEO
CP Wire
Wed, 05/23/18 - 10:26 pm
Kronos Bio
Gilead Sciences
Kronos Bio Appoints Former Gilead R&D Veteran as President and CEO
Wed, 05/23/18 - 09:52 am
Kronos Bio